AKT1 and pancreatic neoplasm: Several studies have linked activation of cMET signaling to phosphorylation of intracellular signaling cascades such as PI3K/Akt, MAPK/ERK or FAK in pancreatic cancer models, leading to tumour cell invasiveness, motility and resistance to gemcitabine therapy [12,13,28-31].